ATOVAQUONE (ATOVAQUONE) — FDA Approval ANDA209685 (GLENMARK SPECLT)
ATOVAQUONE (ATOVAQUONE) — FDA Approval ANDA209685 (GLENMARK SPECLT) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: ATOVAQUONE; Active ingredients: ATOVAQUONE; Application number: ANDA209685.
| Brand name | ATOVAQUONE |
|---|---|
| Active ingredients | ATOVAQUONE |
| Application number | ANDA209685 |
| Sponsor | GLENMARK SPECLT |
| Dosage form | SUSPENSION |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20181121 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →